Inspra® reduces risk of recurrent heart failure hospitalisation – Pharmacy Europe
Inspra® reduces risk of recurrent heart failure hospitalisationPharmacy EuropeResults of this sub-analysis showed that despite fewer deaths in the eplerenone group compared with placebo, there were fewer recurrent hospitalisations. Heart failure hospi…
